Search - tctmd.com

Displaying 1 - 20 of 39

Sort: Relevancy | Date

News Conference News TCT 2025

TTVR Remains Safe, Effective in Presence of CIED Leads

Todd Neale

October 25, 2025

Presentation TCT 2022

TCT 46: Prehospital crushed versus integral prasugrel loading dose in patients presenting with anterior ST-segment elevation myocardial infarction – A COMPARE CRUSH subanalysis

Presenter: Rosanne Vogel

September 17, 2022

Presentation TCT 2022

TCT 28: Pharmacodynamic response, early reperfusion and clinical outcomes to pre-hospital prasugrel administration in diabetic patients presenting with STEMI – A COMPARE CRUSH subanalysis

Presenter: Rosanne Vogel

September 17, 2022

Presentation TCT 2022

TCT 23: Influence of the circadian clock on the pharmacodynamic effect of prasugrel in patients presenting with ST-segment elevation myocardial infarction – A COMPARE CRUSH subanalysis

Presenter: Rosanne Vogel

September 17, 2022

News Daily News

Longer-Term Data Still Worrisome for Impella-Treated AMICS Patients

Caitlin E. Cox

July 20, 2022

News Conference News EuroPCR 2022

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Michael O'Riordan

May 23, 2022

News Conference News TCT 2021

Crushed Prasugrel Loading Dose Still No Benefit at 1 Year in COMPARE CRUSH

Yael L. Maxwell

October 15, 2021

Podcast TCTMD Talking Points

The COMPARE CRUSH Trial

September 22, 2021

Crushing Prasugrel Tabs Ups Platelet Inhibition Following Primary PCI

News Daily News

Crushed Prasugrel in the Ambulance Ups Platelet Inhibition in Primary PCI

Yael L. Maxwell

June 22, 2021

Presentation TCT 2020

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

Presenter: George Vlachojannis

October 14, 2020

News Conference News TCT 2020

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

L.A. McKeown

October 14, 2020

News Daily News

Young Women With AMICS: High Risk, Inadequate Care

L.A. McKeown

September 29, 2020

News Conference News EuroPCR 2020

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

Michael O'Riordan

June 30, 2020

News Daily News

Infective Endocarditis Related to Injecting Opioids on the Rise in Ontario

Todd Neale

January 28, 2019

News Daily News

Crushing It: Cangrelor and Ticagrelor Can Be Used Together Safely in STEMI, Small Study Hints

Todd Neale

January 14, 2019

News Conference News AHA 2017

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Michael O'Riordan

November 12, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day One

Shelley Wood

October 30, 2017

News Conference News TCT 2017

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Yael L. Maxwell

October 30, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Opinion Editor's Corner ESC 2017

My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back

Shelley Wood

September 08, 2017

Advertisement

TTVR Remains Safe, Effective in Presence of CIED Leads

TCT 46: Prehospital crushed versus integral prasugrel loading dose in patients presenting with anterior ST-segment elevation myocardial infarction – A COMPARE CRUSH subanalysis

TCT 28: Pharmacodynamic response, early reperfusion and clinical outcomes to pre-hospital prasugrel administration in diabetic patients presenting with STEMI – A COMPARE CRUSH subanalysis

TCT 23: Influence of the circadian clock on the pharmacodynamic effect of prasugrel in patients presenting with ST-segment elevation myocardial infarction – A COMPARE CRUSH subanalysis

Longer-Term Data Still Worrisome for Impella-Treated AMICS Patients

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Crushed Prasugrel Loading Dose Still No Benefit at 1 Year in COMPARE CRUSH

The COMPARE CRUSH Trial

Crushed Prasugrel in the Ambulance Ups Platelet Inhibition in Primary PCI

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

Young Women With AMICS: High Risk, Inadequate Care

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

Infective Endocarditis Related to Injecting Opioids on the Rise in Ontario

Crushing It: Cangrelor and Ticagrelor Can Be Used Together Safely in STEMI, Small Study Hints

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Live From Denver: TCT 2017, Day One

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content